Art Taveras

Art Taveras

Inga fler pågående positioner
62 år
Health Technology
Consumer Services
Commercial Services

Profil

Dr. Art Taveras was previously employed as a Chief Scientific Officer by X4 Pharmaceuticals, Inc., a Chief Scientific Officer by Comet Therapeutics, Inc., a Chief Scientific Officer & Head-Drug Discovery by Transform Therapeutics, a President & Chief Scientific Officer by Shanghai ChemPartner Co., Ltd., a Vice President-Small Molecule Drug Discovery by Biogen Idec, Inc. (North Carolina), and a Vice President-Drug Discovery & Development by Alantos Pharmaceuticals Holding, Inc. He received his undergraduate degree from Rensselaer Polytechnic Institute, a graduate degree from Rensselaer Polytechnic Institute and a doctorate degree from Rensselaer Polytechnic Institute.

Tidigare kända positioner av Art Taveras

FöretagPositionSlut
X4 PHARMACEUTICALS, INC. Teknisk/Vetenskaplig/F&U Direktör 2025-01-01
Transform Therapeutics
Grundare 2020-11-01
Teknisk/Vetenskaplig/F&U Direktör 2020-07-01
President 2014-12-01
Företagsledare/Principal 2013-01-01
Se detaljerna i Art Taverass erfarenhet

Art Taverass utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

10

Första gradens relationer

7

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag7

Health Technology

Consumer Services

Health Technology

Commercial Services

Health Technology

Health Technology

Transform Therapeutics

  1. Börsen
  2. Insiders
  3. Art Taveras